Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

173 Views

Poster Session: Bacteremia

1823 - Clinical Profile and Antimicrobial Susceptibility of Invasive Extraintestinal Pathogenic Escherichia coli Disease in Hospitalized Adults Aged ≥60 Years

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Co-Author(s)

JD

Joachim Doua, MD, MPH

Janssen Research & Development, Infectious Diseases & Vaccines, Janssen Pharmaceutica
Beerse, Antwerpen, Belgium
JR

Jesús Rodriguez Baño, MD, PhD

University of Sevilla and Biomedicine Institute of Sevilla
Seville, Andalucia, Spain
JG

Jeroen Geurtsen, PhD

Janssen Vaccines & Prevention BV
Leiden, Zuid-Holland, Netherlands
OG

Oscar Go, PhD

Associate Director
Janssen Research & Development
Raritan, New Jersey, United States

Presenting Author(s)

Michal Sarnecki, MD

Medical Leader VX Bern Clin
Janssen Research & Development, Janssen Vaccines
Bern, Bern, Switzerland

Co-Author(s)

TV

Tuba Vilken, PhD

Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp
Antwerp, Antwerpen, Belgium
BS

Bart Spiessens, PhD

Senior Scientific Director Biostatistics
Janssen Research & Development, Infectious Diseases & Vaccines, Janssen Pharmaceutica
Beerse, Antwerpen, Belgium
CV

Christine Vallejo, MD

Emergency Department and Inserm Clinical Investigation Center 1435, Dupuytren University Hospitall
Limoges, Limousin, France
HG

Herman Goossens, MD

Professor
Vaccine & Infectious Disease Institute, University of Antwerp
Antwerp, Antwerpen, Belgium
MB

Marc Bonten, MD, PhD

Julius Center for Health Sciences and Primary Care, University Medical Center
Utrecht, Utrecht, Netherlands
JP

Jan Poolman, PhD

VP Bacterial Vaccines
Bacterial Vaccines Discovery and Early Development, Janssen Vaccines & Prevention B.V.
Leiden, Zuid-Holland, Netherlands
ME

Miquel Ekkelenkamp, MD, PhD

Department of Medical Microbiology, University Medical Center Utrecht
Utrecht, Utrecht, Netherlands